"Vaccines, Inactivated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
| Descriptor ID |
D015164
|
| MeSH Number(s) |
D20.215.894.830
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Inactivated".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Inactivated".
This graph shows the total number of publications written about "Vaccines, Inactivated" by people in this website by year, and whether "Vaccines, Inactivated" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 4 | 6 |
| 2005 | 1 | 6 | 7 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 3 | 4 |
| 2012 | 0 | 3 | 3 |
| 2013 | 2 | 4 | 6 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 6 | 40 | 46 |
| 2018 | 12 | 42 | 54 |
| 2019 | 9 | 13 | 22 |
| 2020 | 2 | 12 | 14 |
| 2021 | 9 | 24 | 33 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines, Inactivated" by people in Profiles.
-
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021 Dec; 10(1):1751-1759.
-
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerg Microbes Infect. 2021 Dec; 10(1):1790-1806.
-
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect. 2021 Dec; 10(1):1555-1573.
-
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect. 2021 Dec; 10(1):1598-1608.
-
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine. Emerg Microbes Infect. 2021 Dec; 10(1):1112-1115.
-
Allergic and cutaneous reactions following inactivated SARS-CoV-2 vaccine (CoronaVac® ) in healthcare workers. Clin Exp Dermatol. 2022 01; 47(1):171-173.
-
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study. J Med Virol. 2022 01; 94(1):279-286.
-
Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies. J Med Virol. 2022 01; 94(1):399-403.
-
Effectiveness of an Inactivated SARS-CoV-2 Vaccine. N Engl J Med. 2021 09 02; 385(10):946-948.
-
The effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older. J Med Virol. 2022 01; 94(1):173-177.